AstraZeneca stock heads into the open after a 0.32 percent drop

At the close on September 21, 2026, AstraZeneca stock had slipped 0.32 percent in London, while the FTSE 100 was near 10,753 points and the shares traded between GBP 123.64 and GBP 125.06.

AstraZeneca stock closed at GBP 124.50 in London on September 21, 2026, down 0.32 percent. The shares underperformed the FTSE 100, which stood near 10,753 points during the session, while AstraZeneca traded between GBP 123.64 and GBP 125.06.

September 21, 2026 in numbers

AstraZeneca plc (ISIN GB0009895292) began the session at GBP 124.50 and recorded turnover of 236,251 shares in the latest reported market data. The stock remained 25.77 percent below its 52-week high of GBP 157.30, while its 52-week low was GBP 107.84.

As Reuters reported on September 21, 2026, AstraZeneca slipped 0.32 percent after the company said its cancer treatment Enhertu had been recommended for European Union approval in early breast cancer.

Next results date on October 30, 2026

The next quarterly results are expected on October 30, 2026, according to finanzen.ch. European equities also gained during the September 21, 2026 session as technology shares advanced and oil prices declined, factors that shaped the broader market setting for AstraZeneca.